Ellison Mark Jason Heath

CIK 0001781982

Chief Development Officer

Filings

Latest Mar 3, 2023

Issuers covered

Showing

6 of 6

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Ellison Mark Jason Heath. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Ellison Mark Jason Heath has filed

Ticker	Issuer	Filings	Last filed
OPNT	Opiant Pharmaceuticals, Inc.	6	Mar 3, 2023

6 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Mar 3, 2023	OPNTOpiant Pharmaceuticals, Inc.	DDisposition	11,736	$20.00	$234,720
Jan 31, 2023	OPNTOpiant Pharmaceuticals, Inc.	SSale	610	$20.26	$12,359
Jan 9, 2023	OPNTOpiant Pharmaceuticals, Inc.	SSale	469	$20.20	$9,474
Jan 5, 2023	OPNTOpiant Pharmaceuticals, Inc.	SSale	1,806	$20.20	$36,481
Jun 29, 2022	OPNTOpiant Pharmaceuticals, Inc.	AGrant	2,000	$0.00	$0
Jan 5, 2022	OPNTOpiant Pharmaceuticals, Inc.	AGrant	12,000	$0.00	$0

Showing 1-6 of 6

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.